We are live on ! Find out more
KZR

Kezar Life Sciences
KZR

Delisted

KZR was delisted on the 8th of May, 2026.

Back to rankings

54 hedge funds and large institutions have $30.9M invested in Kezar Life Sciences in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 9

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0% more funds holding

Funds holding: 54 → 54 (0)

0.31% less ownership

Funds ownership: 5.24% → 4.92% (-0.31%)

60% less capital invested

Capital invested by funds: $77.2M → $30.9M (-$46.3M)

Holders
54
Holders Change
–
Holders Change %
0%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
20
Reduced
9
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$434K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$431K
3
Renaissance Technologies
Renaissance Technologies
New York
+$390K
4
AIM
Alambic Investment Management
California
+$307K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$306K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$4.5M
2
PC
Polar Capital
United Kingdom
-$1.16M
3
SFM
Sphera Funds Management
Israel
-$534K
4
BCP
Berylson Capital Partners
Massachusetts
-$424K
5
Morgan Stanley
Morgan Stanley
New York
-$331K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$138K +$53.4K +1,105 +36%
BCM
27
Bridgeway Capital Management
Texas
$137K +$202K +4,180 New
Charles Schwab
28
Charles Schwab
California
$115K – – –
Marshall Wace
29
Marshall Wace
United Kingdom
$107K -$99K -2,050 -39%
OAM
30
Oxford Asset Management
United Kingdom
$92K +$136K +2,819 New
Barclays
31
Barclays
United Kingdom
$85K +$4.34K +90 +4%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$79K – – –
Bank of America
33
Bank of America
North Carolina
$78K +$38.2K +791 +50%
Deutsche Bank
34
Deutsche Bank
Germany
$78K +$63.2K +1,309 +116%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$72K +$8.98K +186 +9%
IAA
36
Ironsides Asset Advisors
North Carolina
$58K – – –
UBS Group
37
UBS Group
Switzerland
$58K +$69K +1,430 +443%
HSBC Holdings
38
HSBC Holdings
United Kingdom
$52K +$77.1K +1,596 New
Millennium Management
39
Millennium Management
New York
$49K -$228K -4,716 -76%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$42K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$35K – – –
PPA
42
Parametric Portfolio Associates
Washington
$34K +$49.6K +1,028 New
AIG
43
American International Group
New York
$32K -$338 -7 -0.7%
Morgan Stanley
44
Morgan Stanley
New York
$21K -$331K -6,848 -91%
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$14K +$21.2K +440 New
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$7.16K +$97 +2 +0.9%
Legal & General Group
47
Legal & General Group
United Kingdom
$7K – – –
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$6K +$1.88K +39 +30%
SO
49
STRS Ohio
Ohio
$4K – – –
TRCT
50
Tower Research Capital (TRC)
New York
$4K +$5.94K +123 +3,075%
1
2
3

KZR Hedge Fund Activity: Q3 2019 in Review

54 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Kezar Life Sciences (KZR) for Q3 2019, worth a combined $30.9M — down 60% from $77.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new KZR positions and 12 closed out — a net gain of 1 holder — while 20 added to existing stakes and 9 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $434K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $4.5M sold.

  • 54 institutional investors held Kezar Life Sciences (KZR) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $30.9M of Kezar Life Sciences stock for Q3 2019, down 60% quarter-over-quarter.
  • 13 funds opened new Kezar Life Sciences positions in Q3 2019 and 12 closed out, a net change of +1 holder.
  • The largest Kezar Life Sciences buyer in Q3 2019 was Two Sigma Investments, an estimated $434K added.
  • The largest Kezar Life Sciences seller in Q3 2019 was EcoR1 Capital, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2019.